MiNK Therapeutics, Inc. (INKT)
11.84
+0.39
(+3.41%)
USD |
NASDAQ |
Sep 09, 16:00
11.84
0.00 (0.00%)
After-Hours: 16:48
MiNK Therapeutics Total Liabilities (Quarterly) : 23.64M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.64M |
| March 31, 2026 | 23.06M |
| December 31, 2025 | 28.47M |
| September 30, 2025 | 28.48M |
| June 30, 2025 | 27.67M |
| March 31, 2025 | 26.06M |
| December 31, 2024 | 25.31M |
| September 30, 2024 | 24.93M |
| June 30, 2024 | 26.90M |
| March 31, 2024 | 27.19M |
| December 31, 2023 | 22.61M |
| Date | Value |
|---|---|
| September 30, 2023 | 21.04M |
| June 30, 2023 | 21.61M |
| March 31, 2023 | 21.06M |
| December 31, 2022 | 21.87M |
| September 30, 2022 | 18.51M |
| June 30, 2022 | 17.43M |
| March 31, 2022 | 18.83M |
| December 31, 2021 | 16.46M |
| September 30, 2021 | 80.59M |
| June 30, 2021 | 67.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.615M |
| Shareholders Equity (Quarterly) | -14.03M |
| Current Ratio | 1.228 |
| Net Debt Paydown Yield | 1.72% |